Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome.

de Lima M, Champlin RE, Thall PF, Wang X, Martin TG 3rd, Cook JD, McCormick G, Qazilbash M, Kebriaei P, Couriel D, Shpall EJ, Khouri I, Anderlini P, Hosing C, Chan KW, Andersson BS, Patah PA, Caldera Z, Jabbour E, Giralt S.

Leukemia. 2008 Feb;22(2):258-64. Epub 2007 Nov 8.

PMID:
17989720
2.

The role of gemtuzumab ozogamicin in acute leukaemia therapy.

Tsimberidou AM, Giles FJ, Estey E, O'Brien S, Keating MJ, Kantarjian HM.

Br J Haematol. 2006 Feb;132(4):398-409. Review.

PMID:
16412015
3.

What role does gemtuzumab ozogamicin have in the treatment of acute myelogenous leukemia?

Molnár I, Powell BL.

Curr Hematol Malig Rep. 2007 May;2(2):104-10. doi: 10.1007/s11899-007-0015-1. Review.

PMID:
20425358
4.

[Current and new therapeutic strategies in acute myeloid leukemia].

Naito K, Ohnishi K.

Gan To Kagaku Ryoho. 2005 Mar;32(3):292-6. Review. Japanese.

PMID:
15791811
5.

[Therapeutic advances in neoplastic hematology: target therapy anti-CD33].

Di Rocco A, Finolezzi E, Anaclerico B, Calabrese E, Levi A, Trasarti S, Tafuri A.

Clin Ter. 2005 Jul-Aug;156(4):183-6. Review. Italian.

PMID:
16342520
6.

Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia.

Giles F, Estey E, O'Brien S.

Cancer. 2003 Nov 15;98(10):2095-104. Review.

7.
8.

Targeted treatment of acute myeloid leukemia in older adults: role of gemtuzumab ozogamicin.

Duong HK, Sekeres MA.

Clin Interv Aging. 2009;4:197-205. Epub 2009 May 14. Review.

9.

New developments in antibody therapy for acute myeloid leukemia.

Tomblyn MR, Tallman MS.

Semin Oncol. 2003 Aug;30(4):502-8. Review.

PMID:
12939719
10.

Gemtuzumab ozogamicin.

McGavin JK, Spencer CM.

Drugs. 2001;61(9):1317-22; discussion 1323-4. Review.

PMID:
11511025
11.

Antibody therapy for acute myeloid leukemia.

Mulford D.

Semin Hematol. 2008 Apr;45(2):104-9. doi: 10.1053/j.seminhematol.2008.02.008. Review.

PMID:
18381105
12.

Acute and long-term toxicities associated with gemtuzumab ozogamicin (Mylotarg) therapy of acute myeloid leukemia.

Leopold LH, Berger MS, Feingold J.

Clin Lymphoma. 2002 Mar;2 Suppl 1:S29-34. Review.

PMID:
11970768
13.

Current use and future development of gemtuzumab ozogamicin.

Larson RA.

Semin Hematol. 2001 Jul;38(3 Suppl 6):24-31. Review.

PMID:
11474494
14.

Gemtuzumab ozogamicin (mylotarg) for the treatment of acute myeloid leukemia--ongoing trials.

Gleissner B, Schlenk R, Bornhäuser M, Berdel WE.

Onkologie. 2007 Dec;30(12):657-62. Epub 2007 Nov 30. Review.

PMID:
18063879
15.
16.

[Characteristics of hematological malignancies in the elderly].

Ohta M.

Rinsho Ketsueki. 2008 Jun;49(6):382-9. Review. Japanese. No abstract available.

PMID:
18646605

Supplemental Content

Support Center